$4.51 -0.05 (%) Arena Pharmaceuticals Inc - NASDAQ

Jan. 29, 2015 | 04:00 PM

Partner Headlines

  1. CNBC's Stock Pops & Drops From January 21

    Benzinga | Jan. 21, 2015 | 21:14PM EST
  2. Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher

    Benzinga | Jan. 21, 2015 | 15:10PM EST
  3. 4 More Biotech Secondaries Traders Are Watching

    Benzinga | Jan. 21, 2015 | 13:38PM EST
  4. Mid-Day Market Update: U.S. Stocks Surge; Netflix Shares Jump On Upbeat Earnings

    Benzinga | Jan. 21, 2015 | 12:53PM EST
  5. Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations

    Benzinga | Jan. 21, 2015 | 10:42AM EST
  6. Morning Market Losers

    Benzinga | Jan. 21, 2015 | 09:55AM EST
  7. Wednesday Morning Movers: Netflix Flying High

    Benzinga | Jan. 21, 2015 | 08:55AM EST
  8. Arena Pharmaceuticals Announces Agreement to Sell Common Stock

    Benzinga | Jan. 21, 2015 | 08:45AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 21, 2015 | 08:23AM EST
  10. Tuesday's After-Hours Movers: Netflix Leads The Pack

    Benzinga | Jan. 20, 2015 | 17:25PM EST
  11. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  12. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  13. Mid-Afternoon Market Update: Dow Jumps Over 200 Points After Fed Minutes; RPM Shares Drop On Downbeat Results

    Benzinga | Jan. 7, 2015 | 15:17PM EST
  14. Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline

    Benzinga | Jan. 7, 2015 | 13:11PM EST
  15. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates

    Benzinga | Jan. 7, 2015 | 10:59AM EST
  16. Morning Market Gainers

    Benzinga | Jan. 7, 2015 | 09:38AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 7, 2015 | 08:10AM EST
  18. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  19. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  20. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  21. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  22. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 3, 2014 | 08:09AM EST
  23. Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M

    Benzinga | Nov. 3, 2014 | 06:48AM EST
  24. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  25. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 29, 2014 | 08:12AM EST
  27. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  28. Eisai And Arena Pharmaceuticals Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ (lorcaserin HCl) CIV In Postgraduate Medicine

    Benzinga | Oct. 10, 2014 | 11:37AM EST
  29. Earnings Scheduled For August 1, 2014

    Benzinga | Aug. 1, 2014 | 05:23AM EST
  30. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 11, 2014 | 08:19AM EST
  31. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga | Jul. 7, 2014 | 16:37PM EST
  32. Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

    Benzinga | Jul. 7, 2014 | 12:45PM EST
  33. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 7, 2014 | 08:13AM EST
  34. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  35. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  36. Is Arena Pharmaceuticals A Biotech Stock To Watch?

    Benzinga | Jun. 11, 2014 | 14:15PM EST
  37. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  38. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  39. Arena Pharma Posts Q1 Loss Of $0.12/Share, Misses By ~$0.02/Share

    Benzinga | May. 12, 2014 | 18:44PM EST
  40. Earnings Scheduled For May 12, 2014

    Benzinga | May. 12, 2014 | 06:18AM EST
  41. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  42. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 28, 2014 | 08:15AM EST
  43. Earnings Scheduled For February 27, 2014

    Benzinga | Feb. 27, 2014 | 04:29AM EST
  44. Bad Earnings Weigh In On Diet Stocks

    Benzinga | Feb. 14, 2014 | 12:22PM EST
  45. Top Trending Tickers On StockTwits For February 14

    Benzinga | Feb. 14, 2014 | 11:06AM EST
  46. #PreMarket Primer: Friday, February 14: A Turnaround

    Benzinga | Feb. 14, 2014 | 07:26AM EST
  47. Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil

    Benzinga | Feb. 12, 2014 | 08:03AM EST
  48. Celgene To Release Earnings At J.P. Morgan Event Mon.

    IBD | Jan. 12, 2014 | 22:35PM EST
  49. The Top Five Drug Launches Of 2013

    IBD | Dec. 31, 2013 | 13:42PM EST
  50. (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results

    GuruFocus | Nov. 16, 2013 | 14:11PM EST
Trading Center